P
Pfizer Portfolio holdings
AUM
$576M
This Quarter Return
-25.45%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$501M
AUM Growth
+$501M
(-81%)
Cap. Flow
-$1.9B
Cap. Flow
% of AUM
-378.77%
Top 10 Holdings %
Top 10 Hldgs %
96.83%
Holding
23
New
–
Increased
1
Reduced
–
Closed
2
Top Buys
| 1 |
NextCure
NXTC
|
$208K |
Top Sells
| 1 |
Haleon
HLN
|
$1.88B |
| 2 |
Akero Therapeutics
AKRO
|
$15.7M |
Sector Composition
| 1 | Healthcare | 99.99% |
| 2 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
BioNTech
BNTX
$24B
| $333M | 66.51% | 3,658,361 | – | – |
|
2
Allogene Therapeutics
ALLO
$251M
| $32.2M | 6.42% | 22,032,040 | – | – |
|
3
Oric Pharmaceuticals
ORIC
$994M
| $30M | 5.99% | 5,376,344 | – | – |
|
4
Arvinas
ARVN
$568M
| $24.3M | 4.85% | 3,457,815 | – | – |
|
5
Tourmaline Bio
TRML
$601M
| $19.4M | 3.86% | 1,272,214 | – | – |
|
6
Wave Life Sciences
WVE
$1.53B
| $15.2M | 3.02% | 1,875,000 | – | – |
|
7
Biohaven
BHVN
$1.63B
| $12.2M | 2.43% | 505,645 | – | – |
|
8
Cardiff Oncology
CRDF
$140M
| $7.57M | 1.51% | 2,411,575 | – | – |
|
9
Pyxis Oncology
PYXS
$79.4M
| $6.89M | 1.38% | 7,032,770 | – | – |
|
10
Caribou Biosciences
CRBU
$174M
| $4.28M | 0.86% | 4,690,431 | – | – |
|
11
Zura Bio
ZURA
$133M
| $3.83M | 0.77% | 2,970,022 | – | – |
|
12
Celcuity
CELC
$2.17B
| $3.53M | 0.71% | 349,406 | – | – |
|
13
ESSA Pharma
EPIX
$11.4M
| $2.65M | 0.53% | 1,675,000 | – | – |
|
14
Spero Therapeutics
SPRO
$116M
| $1.7M | 0.34% | 2,362,348 | – | – |
|
15
Zentalis Pharmaceuticals
ZNTL
$122M
| $1.52M | 0.3% | 953,834 | – | – |
|
16
AN2 Therapeutics
ANTX
$30.1M
| $973K | 0.19% | 715,295 | – | – |
|
|
17
NextCure
NXTC
$13.5M
| $909K | 0.18% | 1,891,763 +433,213 | +30% | +$208K |
|
18
Q32 Bio
QTTB
$20.9M
| $458K | 0.09% | 277,777 | – | – |
|
19
Bolt Biotherapeutics
BOLT
$9.85M
| $250K | 0.05% | 626,109 | – | – |
|
20
Senseonics Holdings
SENS
$374M
| $28.5K | 0.01% | 43,426 | – | – |
|
21
Ginkgo Bioworks
DNA
$750M
| $16.7K | ﹤0.01% | 2,928 | – | – |
|
|
22
Akero Therapeutics
AKRO
$3.74B
| – | – | -562,626 | Closed | -$15.7M |
|
|
23
Haleon
HLN
$43.9B
| – | – | -197,228,952 | Closed | -$1.88B |
|